Safety, Tolerability, Pharmacokinetics And Pharmacodynamics Study Of PF-06291874 As Oral Monotherapy To Treat Adults With Type 2 Diabetes Mellitus
Public ClinicalTrials.gov record NCT02175121. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2, Randomized, Double-blind, Placebo-controlled, Parallel Group Trial To Assess The Safety, Tolerability, Pharmacokinetics And Pharmacodynamics Of Multiple Oral Doses Of Pf-06291874 Given As Monotherapy To Adults With Type 2 Diabetes Mellitus
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This study is going to assess the safety and tolerability of PF-06291874 in adults with Type 2 Diabetes Mellitus as monotherapy, to evaluate the significance of overall glycemic control in these subjects.
Study identification
- NCT ID
- NCT02175121
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 172 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 70 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jul 31, 2014
- Primary completion
- Feb 28, 2015
- Completion
- Feb 28, 2015
- Last update posted
- Jun 14, 2016
2014 – 2015
United States locations
- U.S. sites
- 19
- U.S. states
- 10
- U.S. cities
- 16
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Anaheim Clinical Trials, LLC | Anaheim | California | 92801 | — |
| Profil Institute for Clinical Research, Inc. | Chula Vista | California | 91911 | — |
| Diablo Clinical Research, Inc. | Walnut Creek | California | 94598 | — |
| Avail Clinical Research, LLC | DeLand | Florida | 32720 | — |
| SeaView Research, Inc. | Miami | Florida | 33125 | — |
| SeaView Research, Inc. | Miami | Florida | 33126 | — |
| Compass Research, LLC | Orlando | Florida | 32806 | — |
| Miami Research Associates, Inc. | South Miami | Florida | 33143 | — |
| MRA Clinical Research, LLC | South Miami | Florida | 33143 | — |
| MRA Clinical Research | South Miami | Florida | 33143 | — |
| Louisville Metabolic and Atherosclerosis Research Center | Louisville | Kentucky | 40213 | — |
| DaVita Clinical Research | Minneapolis | Minnesota | 55404 | — |
| Clinilabs, Inc. | Eatontown | New Jersey | 07724 | — |
| PRA International | Marlton | New Jersey | 08053 | — |
| Buffalo Clinical Research Center, LLC | Buffalo | New York | 14202 | — |
| High Point Clinical Trials Center, LLC | High Point | North Carolina | 27265 | — |
| Community Research | Cincinnati | Ohio | 45255 | — |
| Clinical Trials of Texas, Inc. | San Antonio | Texas | 78229 | — |
| Rainier Clinical Research Center, Inc. | Renton | Washington | 98057 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02175121, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jun 14, 2016 · Synced Sep 3, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT02175121 live on ClinicalTrials.gov.